As ALK inhibition by crizotinib abolished the effect of the HDAC8 inhibitor on AKT but strongly inhibited ERK, which resulted in enhanced cell death, we hypothesized that RTK inhibition shifts the HDAC8 inhibitor-mediated differentiation phenotype toward neuroblastoma cell death. The gene discussed is AKT1; the disease is neuroblastoma.